Clinical Trial Update: Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting identification of predictive biomarkers for response to biologic therapies and tofacitinib in inflammatory bowel disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Inflammatory Bowel Diseases, Crohn Disease | Phase 4 | Status: COMPLETED